Quarterly report · Q2

Period2023-01-21 → 2023-07-20
Filed2023-09-01
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥101.7bn2023-01-21 → 2023-07-20Cons.Net sales
Revenue¥160.1bn2022-01-21 → 2023-01-20Cons.Net sales (5-year summary)
Revenue¥79.8bn2022-01-21 → 2022-07-20Cons.Net sales
Operating income¥2.5bn2023-01-21 → 2023-07-20Cons.Operating income
Operating income¥723m2022-01-21 → 2022-07-20Cons.Operating income
Ordinary income¥1.8bn2023-01-21 → 2023-07-20Cons.Ordinary income
Ordinary income¥591m2022-01-21 → 2023-01-20Cons.Ordinary income loss (5-year summary)
Ordinary income¥461m2022-01-21 → 2022-07-20Cons.Ordinary income
Profit before tax¥4.1bn2023-01-21 → 2023-07-20Cons.Income before income taxes
Profit before tax¥351m2022-01-21 → 2022-07-20Cons.Income before income taxes
Net income (owners)¥2.3bn2023-01-21 → 2023-07-20Cons.Profit loss attributable to owners of parent
Net income (owners)−¥507m2022-01-21 → 2023-01-20Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥869m2022-01-21 → 2022-07-20Cons.Profit loss attributable to owners of parent
Net income¥2.4bn2023-01-21 → 2023-07-20Cons.Profit loss
Net income−¥909m2022-01-21 → 2022-07-20Cons.Profit loss
Total assets¥182.1bnat 2023-07-20Cons.Assets
Total assets¥164.2bnat 2023-01-20Cons.Assets
Total assets¥170.3bnat 2022-07-20Cons.Total assets (5-year summary)
Total liabilities¥94.3bnat 2023-07-20Cons.Liabilities
Total liabilities¥80.1bnat 2023-01-20Cons.Liabilities
Net assets / equity¥87.8bnat 2023-07-20Cons.Net assets
Net assets / equity¥84.1bnat 2023-01-20Cons.Net assets
Net assets / equity¥84.3bnat 2022-07-20Cons.Net assets (5-year summary)
Cash and deposits¥30.0bnat 2023-07-20Cons.Cash and deposits
Cash and deposits¥27.2bnat 2023-01-20Cons.Cash and deposits
Cash & equivalents¥33.0bnat 2023-07-20Cons.Cash and cash equivalents
Cash & equivalents¥29.2bnat 2023-01-20Cons.Cash and cash equivalents
Cash & equivalents¥28.8bnat 2022-07-20Cons.Cash and cash equivalents
Cash & equivalents¥30.1bnat 2022-01-20dCons.Cash and cash equivalents
Operating cash flow¥2.7bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in operating activities
Operating cash flow¥5.1bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥423m2022-01-21 → 2022-07-20Cons.Net cash provided by used in operating activities
Investing cash flow¥1.4bn2023-01-21 → 2023-07-20Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.0bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.8bn2022-01-21 → 2022-07-20Cons.Net cash provided by used in investment activities
Financing cash flow−¥50m2023-01-21 → 2023-07-20Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.1bn2022-01-21 → 2023-01-20Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.7bn2022-01-21 → 2022-07-20Cons.Net cash provided by used in financing activities
EPS (basic)¥149.292023-01-21 → 2023-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.122023-04-21 → 2023-07-20dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.42022-01-21 → 2023-01-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-55.542022-01-21 → 2022-07-20Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.772022-04-21 → 2022-07-20dCons.Basic earnings loss per share (5-year summary)
Equity ratio47.2%at 2023-07-20Cons.Equity to asset ratio (5-year summary)
Equity ratio50.9%at 2023-01-20Cons.Equity to asset ratio (5-year summary)
Equity ratio49.3%at 2022-07-20Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingrevenue intersegment2023-01-21 → 2023-07-20−¥204m
Reconciling Itemsreconcilingsegment profit2023-01-21 → 2023-07-20−¥502m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥74.3bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥74.2bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥19m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥1.8bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2023-01-21 → 2023-07-20−¥296m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥3m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥776m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥10.5bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥462m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2023-01-21 → 2023-07-20¥6.4bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2023-01-21 → 2023-07-20¥6.2bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2023-01-21 → 2023-07-20¥180m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2023-01-21 → 2023-07-20¥239m
—segment totalrevenue2023-01-21 → 2023-07-20¥102.0bn
—segment totalrevenue external2023-01-21 → 2023-07-20¥101.7bn
—segment totalrevenue intersegment2023-01-21 → 2023-07-20¥204m
—segment totalsegment profit2023-01-21 → 2023-07-20¥3.0bn
Reconciling Itemsreconcilingrevenue2022-01-21 → 2022-07-20−¥302m
Reconciling Itemsreconcilingrevenue intersegment2022-01-21 → 2022-07-20−¥302m
Reconciling Itemsreconcilingsegment profit2022-01-21 → 2022-07-20−¥615m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥54.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥54.0bn
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥21m
jpcrp040300-q2r_E00424-000Domestic Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥1.4bn
jpcrp040300-q2r_E00424-000Dy Do Pharmareportable segmentsegment profit2022-01-21 → 2022-07-20−¥269m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥10.8bn
jpcrp040300-q2r_E00424-000Food Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥4m
jpcrp040300-q2r_E00424-000Food Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥908m
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥9.3bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥9.3bn
jpcrp040300-q2r_E00424-000International Beverage Businessreportable segmentsegment profit2022-01-21 → 2022-07-20−¥735m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue2022-01-21 → 2022-07-20¥6.0bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue external2022-01-21 → 2022-07-20¥5.7bn
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentrevenue intersegment2022-01-21 → 2022-07-20¥276m
jpcrp040300-q2r_E00424-000Pharmaceutical Related Businessreportable segmentsegment profit2022-01-21 → 2022-07-20¥66m
—segment totalrevenue2022-01-21 → 2022-07-20¥80.1bn
—segment totalrevenue external2022-01-21 → 2022-07-20¥79.8bn
—segment totalrevenue intersegment2022-01-21 → 2022-07-20¥302m
—segment totalsegment profit2022-01-21 → 2022-07-20¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 564
ItemContextValueUnit
Loss on disaster ope cfCurrentYTDDuration-JPY
Losses on net monetary position ope cfPrior1YTDDuration307000000JPY
Losses on net monetary position ope cfCurrentYTDDuration5000000JPY
Insurance income ope cf2Prior1YTDDuration-JPY
Insurance income ope cf2CurrentYTDDuration-421000000JPY
Loss gain on valuation of investment securities ope cfPrior1YTDDuration-JPY
Loss gain on valuation of investment securities ope cfCurrentYTDDuration82000000JPY
Loss gain on sales of investment securities ope cfPrior1YTDDuration-JPY
Loss gain on sales of investment securities ope cfCurrentYTDDuration-2025000000JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YTDDuration-6039000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration-7614000000JPY
Decrease increase in inventories ope cfPrior1YTDDuration-3091000000JPY
Decrease increase in inventories ope cfCurrentYTDDuration-3611000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YTDDuration6859000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration8027000000JPY
Increase decrease in accounts payable other ope cfPrior1YTDDuration-445000000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration69000000JPY
Decrease increase in other assets ope cfPrior1YTDDuration-974000000JPY
Decrease increase in other assets ope cfCurrentYTDDuration-471000000JPY
Increase decrease in other liabilities ope cfPrior1YTDDuration-124000000JPY
Increase decrease in other liabilities ope cfCurrentYTDDuration761000000JPY
Subtotal ope cfPrior1YTDDuration1103000000JPY
Subtotal ope cfCurrentYTDDuration3517000000JPY
Interest and dividends income received ope cf inv cfPrior1YTDDuration78000000JPY
Interest and dividends income received ope cf inv cfCurrentYTDDuration161000000JPY
Interest expenses paid ope cf fin cfPrior1YTDDuration-106000000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-217000000JPY
Payments for loss on disaster ope cfPrior1YTDDuration-23000000JPY
Payments for loss on disaster ope cfCurrentYTDDuration-JPY
Income taxes paid ope cfPrior1YTDDuration-1474000000JPY
Income taxes paid ope cfCurrentYTDDuration-775000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration-423000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration2685000000JPY
Payments into time deposits inv cfPrior1YTDDuration-3600000000JPY
Payments into time deposits inv cfCurrentYTDDuration-1999000000JPY
Proceeds from withdrawal of time deposits inv cfPrior1YTDDuration4588000000JPY
Proceeds from withdrawal of time deposits inv cfCurrentYTDDuration3547000000JPY
Purchase of short term investment securities inv cfPrior1YTDDuration-6200000000JPY
Purchase of short term investment securities inv cfCurrentYTDDuration-6200000000JPY
Proceeds from sales and redemption of securities inv cfPrior1YTDDuration7200000000JPY
Proceeds from sales and redemption of securities inv cfCurrentYTDDuration6400000000JPY
Purchase of property plant and equipment and intangible assets inv cfPrior1YTDDuration-4502000000JPY
Purchase of property plant and equipment and intangible assets inv cfCurrentYTDDuration-5841000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration24000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration58000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-605000000JPY
Purchase of investment securities inv cfCurrentYTDDuration-305000000JPY
Proceeds from sales and redemption of investment securities inv cfPrior1YTDDuration391000000JPY
Proceeds from sales and redemption of investment securities inv cfCurrentYTDDuration2901000000JPY
Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1YTDDuration-JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-01-20pass
balance sheet identityconsolidated 2023-07-20pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-01-20pass
statement vs summary · net assetsconsolidated 2023-07-20pass
statement vs summary · net income attributable to parentconsolidated 2022-01-21/2022-07-20pass
statement vs summary · net income attributable to parentconsolidated 2023-01-21/2023-07-20pass
statement vs summary · operating cash flowconsolidated 2022-01-21/2022-07-20pass
statement vs summary · operating cash flowconsolidated 2023-01-21/2023-07-20pass
statement vs summary · revenueconsolidated 2022-01-21/2022-07-20pass
statement vs summary · revenueconsolidated 2023-01-21/2023-07-20pass
statement vs summary · total assetsconsolidated 2023-01-20pass
statement vs summary · total assetsconsolidated 2023-07-20pass